Bivalirudin (Angiomax)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bivalirudin (Angiomax), covering 2013-08-01 to 2014-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients [Phase 3]